Navigation Links
ARIUS Announces Third Quarter Fiscal 2007 Financial Results
Date:10/12/2007

TORONTO, Oct. 12 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced its financial and operational results for the third quarter, ended August 31, 2007.

"Our third quarter of fiscal 2007 was one of preparation as we worked towards moving our lead drug candidate AR001 into human clinical trials in 2008, while also building value in our business and our pipeline through the progression of our other antibody anti-cancer candidates," said Dr. David Young, President and CEO. "Our most important development this quarter and a milestone step for ARIUS, was the initiation of a pre-clinical dose-finding toxicology study for AR001, our CD44 targeting anti-cancer antibody."

Program Updates:

CD44 Cancer Stem Cell Program

ARIUS initiated a pre-clinical dose-finding study, commencing its IND-enabling toxicology program for its lead anti-CD44 antibody. The Company expects to file a Phase I IND application and begin human clinical trials in 2008. The Company engaged a manufacturer for process development and manufacturing of its lead antibody under Current Good Manufacturing Practices ("cGMP").

Trop-2 Signal Transduction Program

ARIUS has successfully humanized its anti-Trop-2 antibody, which continues to retain its binding characteristics and in vivo activity. The Company also selected a manufacturer for the antibody. The Company expects to perform pre-clinical toxicology studies in 2008 in preparation for filing a Phase I IND application in 2008.

CD59 Complement Inhibitor Program

In collaboration with Antitope Limited, ARIUS has successfully humanized its CD59 targeting antibody, retaining its binding characteristics and in vivo activity. The Company expects to perform preclinical toxicology studies in 2008 in preparation for filing a Phase I IND application.

CD63 Antibody Program

The Genentech-partnere
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Streptococcus salivarius
2. Streptococcus salivarius
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswire-...alottoCapitalInc.,aleadingproviderofadvancedlasers...lityclinicmarkets,todayreportedoperationalandfinan.... , ,Q32009Highlights,-Revenuewas$1.46millioncom...s66.3percentcomparedwith66.1percentinQ3,2008,-Netl...
(Date:11/24/2009)..., BOZEN,Italy,November24/PRNewswire/--HealthRoboti...enturewithagroupofselected,investors.Thisrecentlyf...ealthRoboticsCanada,Inc.andwillmarket,install,ands...hichincludesthe,revolutionaryproductofferingsi.v.S...CanadaInc.willalsoprovideassistanceonan"asneeded,b...
(Date:11/23/2009)...T LAKE CITY, Nov. 23, 2009 In a provocative new s...ising carbon dioxide emissions the major cause of...orld,s economy collapses or society builds the equ..., "It looks unlikely that there will be any subs... acceleration in carbon dioxide emission rates," s...
(Date:11/23/2009)..., INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-FirstCall/...cedthatNASDAQhasestablishedNovember27,2009astheex-...kholdersresultingfromthesecuritizationtransactionc...cember15,2009toallstockholdersofrecordontherecordd...areamountofthedividendat$1.67pershareofcommonstock...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
... Multiporator , , , , , , ... Protocol , Protocol No. 4308 915.030 ... , , , , , , ... epitheloid carcinoma, , , ...FP-N1 (in bidistilled H 2 O), , ...
... Multiporator , , , , , , ... Protocol , Protocol No. 4308 915.033 ... , , , , , , ...ma T-cell line, , , ...in bidistilled H 2 O), , , ...
... Multiporator / Electroporator 2510 , , ,... Transformation Protocol , Pr... , , , , , , , ,... Escherichia coli C600, , ... gram negative, , , ...
Other Biology Technology:HeLa 2EL 4 2Escherichia coli C600 2Escherichia coli C600 3
(Date:11/24/2009)... thousands of years it has been prescribed by trad...ents from headaches and stomach pain to fever and ...castle University have been able to scientifically...enata otherwise known as Brazilian mint. , Test...team led by researcher Graciela Rocha was able to ...
(Date:11/24/2009)... Lupus Research Institute (LRI) today named 12 new...3.6 million, recognize innovative work across a br...for their creativity, novelty, and potential to dr...eat, and cure the complex disease of systemic lupu...hed lupus researchers across the nation and includ...
(Date:11/24/2009)...ket science is opening new doors to understanding ... the hearing of a marine mammal or if they hear i...zed X-ray scanners that NASA uses to detect flaws ... is now allowing scientists to peek inside the gia...ed three-dimensional replicas of a whale,s hearing...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Rocket science leads to new whale discovery 2Elsevier Launches SciVal Spotlight 3A New Tool Provides Multidisciplinary View of Research Performance 50284 1Elsevier Launches SciVal Spotlight 3A New Tool Provides Multidisciplinary View of Research Performance 50284 2Elsevier Launches SciVal Spotlight 3A New Tool Provides Multidisciplinary View of Research Performance 50284 3Elsevier Launches SciVal Spotlight 3A New Tool Provides Multidisciplinary View of Research Performance 50284 4IU researchers find vibrator use to be common linked to sexual health 50281 1IU researchers find vibrator use to be common linked to sexual health 50281 2IU researchers find vibrator use to be common linked to sexual health 50281 3Two is not company as far as fish are concerned 9044 1
...m the University of Turin, Italy and the Universit... method that may help the medical community to det...Their findings are described in an article publish...utational Biology. , Thousands of human diseases...entification of mutated genes is a crucial first s...
...Y, March 27, 2008 -Sustaining hope in the face of ...c lateral sclerosis (ALS) should be a goal of pall...a continuum from focusing on the self to concern f...e April issue (Volume 8, Number 3) of Journal of P...eer-reviewed publication of Mary Ann Liebert, Inc ...
... armed beetle is proving that size doesnt necessar...eatures pulling techniques will be revealed in the... Ecological Entomology journal. , In the world of...often fight for mating rights and those with the l...s is not always the case with one particular speci...
Other Biology News:Hope among patients with ALS may take a variety of forms 2
Rat Big Endothelin-1 (Big ET-1) EIA Kit from Assay Designs/Stressgen Bioreagents
Goat Anti-Qa-1 (L-12) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat TIMP-1 ELISA Kit from R&D Systems
Mouse Anti-Mouse Qa-1 Monoclonal Antibody, Unconjugated, Clone 6A8.6F10 from Santa Cruz Biotechnology, Inc.
Biology Products: